Zynex Company Top Insiders

ZYXI Stock  USD 8.08  0.19  2.30%   
Zynex employs about 1.1 K people. The company is managed by 10 executives with a total tenure of roughly 18 years, averaging almost 1.0 years of service per executive, having 110.0 employees per reported executive. Assessment of Zynex's management performance can provide insight into the firm performance.
Thomas Sandgaard  Chairman
Chairman, CEO and President Principal Financial Officer and Principal Accounting Officer
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Zynex Management Team Effectiveness

The company has return on total asset (ROA) of 0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1023 %, meaning that it created $0.1023 on every $100 dollars invested by stockholders. Zynex's management efficiency ratios could be used to measure how well Zynex manages its routine affairs as well as how well it operates its assets and liabilities.

Zynex Workforce Comparison

Zynex Inc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 193,929. Zynex maintains roughly 1,100 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.

Zynex Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zynex insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zynex's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Zynex insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Zynex Notable Stakeholders

A Zynex stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Zynex often face trade-offs trying to please all of them. Zynex's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Zynex's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Thomas SandgaardChairman, CEO and President Principal Financial Officer and Principal Accounting OfficerProfile
Donald GreggPresident SolutionsProfile
Anna LucsokChief OfficerProfile
Dave AnttilaDirector HRProfile
Daniel MoorheadChief OfficerProfile
Daniel CPAChief OfficerProfile
Steve FoxExecutive SalesProfile
Chelle BurkleoVP SalesProfile
Joachim SandgaardInformation MangProfile
Neil FrieryI SolutionsProfile

About Zynex Management Performance

The success or failure of an entity such as Zynex Inc often depends on how effective the management is. Zynex management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Zynex management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Zynex management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain and activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Zynex operates under Medical Distribution classification in the United States and is traded on NASDAQ Exchange. It employs 774 people.

Zynex Workforce Analysis

Traditionally, organizations such as Zynex use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Zynex within its industry.

Zynex Manpower Efficiency

Return on Zynex Manpower

Revenue Per Employee167.6K
Revenue Per Executive18.4M
Net Income Per Employee8.8K
Net Income Per Executive973.2K
Working Capital Per Employee63K
Working Capital Per Executive6.9M

Complementary Tools for Zynex Stock analysis

When running Zynex's price analysis, check to measure Zynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zynex is operating at the current time. Most of Zynex's value examination focuses on studying past and present price action to predict the probability of Zynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zynex's price. Additionally, you may evaluate how the addition of Zynex to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamental Analysis
View fundamental data based on most recent published financial statements
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Stocks Directory
Find actively traded stocks across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal